Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Depreciation and Depletion (2017 - 2025)

Neuronetics (STIM) has disclosed Depreciation and Depletion for 9 consecutive years, with -$110000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion fell 650.0% to -$110000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $80000.0, a 0.0% change, with the full-year FY2024 number at $90000.0, changed 0.0% from a year prior.
  • Depreciation and Depletion was -$110000.0 for Q3 2025 at Neuronetics, down from $140000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $140000.0 in Q2 2025 to a low of -$110000.0 in Q3 2025.
  • A 5-year average of $19473.7 and a median of $20000.0 in 2021 define the central range for Depreciation and Depletion.
  • Biggest YoY gain for Depreciation and Depletion was 600.0% in 2025; the steepest drop was 650.0% in 2025.
  • Neuronetics' Depreciation and Depletion stood at $20000.0 in 2021, then skyrocketed by 50.0% to $30000.0 in 2022, then crashed by 33.33% to $20000.0 in 2023, then skyrocketed by 50.0% to $30000.0 in 2024, then tumbled by 466.67% to -$110000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Depreciation and Depletion are -$110000.0 (Q3 2025), $140000.0 (Q2 2025), and $20000.0 (Q1 2025).